These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
202 related items for PubMed ID: 11410869
1. Induction of apoptosis by cyclo-oxygenase-2 inhibitor NS398 through a cytochrome C-dependent pathway in esophageal cancer cells. Li M, Wu X, Xu XC. Int J Cancer; 2001 Jul 15; 93(2):218-23. PubMed ID: 11410869 [Abstract] [Full Text] [Related]
2. Induction of apoptosis in colon cancer cells by cyclooxygenase-2 inhibitor NS398 through a cytochrome c-dependent pathway. Li M, Wu X, Xu XC. Clin Cancer Res; 2001 Apr 15; 7(4):1010-6. PubMed ID: 11309352 [Abstract] [Full Text] [Related]
3. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells. Sun Y, Tang XM, Half E, Kuo MT, Sinicrope FA. Cancer Res; 2002 Nov 01; 62(21):6323-8. PubMed ID: 12414664 [Abstract] [Full Text] [Related]
4. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells. Liu XH, Yao S, Kirschenbaum A, Levine AC. Cancer Res; 1998 Oct 01; 58(19):4245-9. PubMed ID: 9766645 [Abstract] [Full Text] [Related]
5. Cyclooxygenase (COX) inhibitors induce apoptosis in non-small cell lung cancer through cyclooxygenase independent pathways. Sánchez-Alcázar JA, Bradbury DA, Pang L, Knox AJ. Lung Cancer; 2003 Apr 01; 40(1):33-44. PubMed ID: 12660005 [Abstract] [Full Text] [Related]
6. Enhancement of chemotherapeutic drug-induced apoptosis by a cyclooxygenase-2 inhibitor in hypopharyngeal carcinoma cells. Peng JP, Liu LT, Chang HC, Hung WC. Cancer Lett; 2003 Nov 25; 201(2):157-63. PubMed ID: 14607329 [Abstract] [Full Text] [Related]
7. Cyclooxygenase-2 level and culture conditions influence NS398-induced apoptosis and caspase activation in lung cancer cells. Chang HC, Weng CF. Oncol Rep; 2001 Nov 25; 8(6):1321-5. PubMed ID: 11605058 [Abstract] [Full Text] [Related]
12. Inhibition of paclitaxel-induced apoptosis by the specific COX-2 inhibitor, NS398, in epithelial ovarian cancer cells. Munkarah AR, Genhai Z, Morris R, Baker VV, Deppe G, Diamond MP, Saed GM. Gynecol Oncol; 2003 Mar 25; 88(3):429-33. PubMed ID: 12648598 [Abstract] [Full Text] [Related]
13. A selective cyclooxygenase-2 inhibitor, NS398, inhibits cell growth and induces cell cycle arrest in the G2/M phase in human esophageal squamous cell carcinoma cells. Kase S, Osaki M, Honjo S, Takeda A, Adachi K, Araki K, Ito H. J Exp Clin Cancer Res; 2004 Jun 25; 23(2):301-7. PubMed ID: 15354416 [Abstract] [Full Text] [Related]
17. NS398 reduces hypoxia-inducible factor (HIF)-1alpha and HIF-1 activity: multiple-level effects involving cyclooxygenase-2 dependent and independent mechanisms. Zhong H, Willard M, Simons J. Int J Cancer; 2004 Nov 20; 112(4):585-95. PubMed ID: 15382039 [Abstract] [Full Text] [Related]
18. Induction of p27(KIP1) as a mechanism underlying NS398-induced growth inhibition in human lung cancer cells. Hung WC, Chang HC, Pan MR, Lee TH, Chuang LY. Mol Pharmacol; 2000 Dec 20; 58(6):1398-403. PubMed ID: 11093779 [Abstract] [Full Text] [Related]
19. Celecoxib activates a novel mitochondrial apoptosis signaling pathway. Jendrossek V, Handrick R, Belka C. FASEB J; 2003 Aug 20; 17(11):1547-9. PubMed ID: 12824303 [Abstract] [Full Text] [Related]
20. Non-steroidal anti-inflammatory drugs inhibit cellular proliferation and upregulate cyclooxygenase-2 protein expression in endometrial cancer cells. Gao J, Niwa K, Sun W, Takemura M, Lian Z, Onogi K, Seishima M, Mori H, Tamaya T. Cancer Sci; 2004 Nov 20; 95(11):901-7. PubMed ID: 15546508 [Abstract] [Full Text] [Related] Page: [Next] [New Search]